Letter: Thrombolytic therapy in haemolytic-uraemic syndrome.
D002648:Child; D004176:Dipyridamole / Q000627:therapeutic use; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D012790:Shwartzman Phenomenon; D013300:Streptokinase / Q000627:therapeutic use
D004176:Dipyridamole; D006493:Heparin; D013300:Streptokinase